Evidence map›Paper›PMID 27571975›Full record

ArticleNature microbiology2016

Genomic diversity of EPEC associated with clinical presentations of differing severity.

Tracy H Hazen, Michael S Donnenberg, Sandra Panchalingam, Martin Antonio, Anowar Hossain, Inacio Mandomando, John Benjamin Ochieng, Thandavarayan Ramamurthy, Boubou Tamboura, Shahida Qureshi and 8 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Nature microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
9.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 91 citations in OpenAlex.

  1. Article
  2. EnteropathogeniceLife · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Whole genome sequencing analysis of enteropathogenicJournal of veterinary science · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 10 institutions in 8 countries.

Tracy H HazenUniversity of Maryland School of Medicine, Institute for Genome Sciences, 801 W. Baltimore Street, Room 600, Baltimore, Maryland 21201, USA.
Michael S DonnenbergDepartment of Medicine, University of Maryland School of Medicine, University of Maryland Medical Center, N3W42, 22 S. Greene Street, Baltimore, Maryland 21201, USA.
Sandra PanchalingamCenter for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, Maryland 21201, USA.
Martin AntonioMedical Research Council Unit, Atlantic Boulevard, Fajara, P.O. Box 273, Banjul, Gambia.
Anowar HossainICDDR, B, GPO Box 128, Dhaka 1000, Bangladesh.
Inacio MandomandoCentro de Investigacao em Saude, Manhica, Rua 12, Cambeve, Vila de Manhiça, CP 1929, Maputo, Mozambique.
John Benjamin OchiengKenya Medical Research Institute/CDC, P.O. Box 54840 - 00200, Kisumu, Kenya.
Thandavarayan RamamurthyNational Institute of Cholera and Enteric Diseases, P-33, C.I.T. Road, Scheme XM, Beleghata, Kolkata 700 010, India.
Boubou TambouraCenter for Vaccine Development - Mali, Bamako, Mali.
Shahida QureshiThe Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan.
Farheen QuadriThe Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan.
Anita ZaidiThe Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Pakistan.
Karen L KotloffCenter for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, Maryland 21201, USA.
Myron M LevineCenter for Vaccine Development, University of Maryland School of Medicine, 685 West Baltimore Street, Room 480, Baltimore, Maryland 21201, USA.
Eileen M BarryDepartment of Microbiology and Immunology, University of Maryland School of Medicine, 685 West Baltimore Street, HSF-I Suite 380, Baltimore, Maryland 21201, USA.
James B KaperDepartment of Microbiology and Immunology, University of Maryland School of Medicine, 685 West Baltimore Street, HSF-I Suite 380, Baltimore, Maryland 21201, USA.
David A RaskoUniversity of Maryland School of Medicine, Institute for Genome Sciences, 801 W. Baltimore Street, Room 600, Baltimore, Maryland 21201, USA.
James P NataroDepartment of Pediatrics, University of Virginia School of Medicine, P.O. Box 800386, Charlottesville, Virginia 22908, USA.
University of Maryland, Baltimore · USAga Khan University · PKUniversity of Maryland Medical Center · USCentre Pour le Développement des Vaccins-Mali · MLInternational Centre for Diarrhoeal Disease Research · BDKenya Medical Research Institute · KEManhiça Health Research Centre · MZMRC Unit the Gambia · GMNational Institute of Cholera and Enteric Diseases · INUniversity of Virginia · US

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI FRASER, CLAIRE M., RASKO, DAVID A · 2014 to 2023
$36.5M
Severe Enteric Disease: Pathogenesis and ResponseU19AI090873 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI KAPER, JAMES B · 2010 to 2014
$7.2M
Medical Research Council MC_U190074190Medical Research Council MC_U190081991Medical Research Council MC_UP_A900_1122NIAID NIH HHS U19 AI090873NIAID NIH HHS U19 AI110820
6 · The paper itself

Abstract

Enteropathogenic Escherichia coli (EPEC) are diarrhoeagenic E. coli, and are a significant cause of gastrointestinal illness among young children in developing countries. Typical EPEC are identified by the presence of the bundle-forming pilus encoded by a virulence plasmid, which has been linked to an increased severity of illness, while atypical EPEC lack this feature. Comparative genomics of 70 total EPEC from lethal (LI), non-lethal symptomatic (NSI) or asymptomatic (AI) cases of diarrhoeal illness in children enrolled in the Global Enteric Multicenter Study was used to investigate the genomic differences in EPEC isolates obtained from individuals with various clinical outcomes. A comparison of the genomes of isolates from different clinical outcomes identified genes that were significantly more prevalent in EPEC isolates of symptomatic and lethal outcomes than in EPEC isolates of asymptomatic outcomes. These EPEC isolates exhibited previously unappreciated phylogenomic diversity and combinations of virulence factors. These comparative results highlight the diversity of the pathogen, as well as the complexity of the EPEC virulence factor repertoire.

Indexed as

Genetic VariationDiarrheaEnteropathogenic Escherichia coliEscherichia coli InfectionsGenes, BacterialGenomicsHumansPhylogenyVirulence FactorsVirulence Factors

Identifiers

PMID27571975
PMCPMC5067155
OpenAlexW2528526568

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.